Literature DB >> 18242184

Differential effect of NF-kappaB activity on beta-catenin/Tcf pathway in various cancer cells.

Hyun Hwa Cho1, Ji Sun Song, Ji Min Yu, Sung Sook Yu, Sung Jong Choi, Dong Heon Kim, Jin Sup Jung.   

Abstract

beta-Catenin/Tcf and NF-kappaB pathways play an important role in biological functions. We determined the underlying mechanisms of differential interaction between two pathways in various human cancer cell lines. NF-kappaB positively regulated beta-catenin/Tcf pathways in human glioblastoma, whereas it has an opposite effect on beta-catenin/Tcf pathways in colon, liver, and breast cancer cells. Expression of lucine zipper tumor suppressor 2 (lzts2) was positively regulated by NF-kappaB activity in colon, liver, and breast cancer cells, whereas negatively regulated in glioma cells. Downregulation of lzts2 increased the beta-catenin/Tcf promoter activity and inhibited NF-kappaB-induced modulation of the nuclear translocation of beta-catenin. These data indicate that the differential crosstalk between beta-catenin/Tcf and NF-kappaB pathway in various cancer cells is resulted from the differences in the regulation of NF-kappaB-induced lzts2 expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18242184     DOI: 10.1016/j.febslet.2008.01.029

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  20 in total

1.  Effect of the modulation of leucine zipper tumor suppressor 2 expression on proliferation of various cancer cells functions as a tumor suppressor.

Authors:  Jong Myung Kim; Ji Sun Song; Hyun Hwa Cho; Keun Koo Shin; Yong Chan Bae; Byung Ju Lee; Jin Sup Jung
Journal:  Mol Cell Biochem       Date:  2010-10-02       Impact factor: 3.396

2.  Inhibition of cathepsin L sensitizes human glioma cells to ionizing radiation in vitro through NF-κB signaling pathway.

Authors:  Neng Yang; Pan Wang; Wen-juan Wang; Yun-zhen Song; Zhong-qin Liang
Journal:  Acta Pharmacol Sin       Date:  2015-02-09       Impact factor: 6.150

3.  Axonal neuregulin 1 type III activates NF-kappaB in Schwann cells during myelin formation.

Authors:  Allison S Limpert; Bruce D Carter
Journal:  J Biol Chem       Date:  2010-04-01       Impact factor: 5.157

4.  Cross-Regulation Between Wnt and NF-κB Signaling Pathways.

Authors:  Qiang Du; David A Geller
Journal:  For Immunopathol Dis Therap       Date:  2010

Review 5.  Aerobic Glycolysis Hypothesis Through WNT/Beta-Catenin Pathway in Exudative Age-Related Macular Degeneration.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rémy Guillevin; Jean-Noël Vallée
Journal:  J Mol Neurosci       Date:  2017-07-08       Impact factor: 3.444

6.  Annexin A2 mediates up-regulation of NF-κB, β-catenin, and stem cell in response to progastrin in mice and HEK-293 cells.

Authors:  Shubhashish Sarkar; Rafal Swiercz; Carla Kantara; Katherine A Hajjar; Pomila Singh
Journal:  Gastroenterology       Date:  2010-09-06       Impact factor: 22.682

Review 7.  Interactions Between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma on Neuroinflammation, Demyelination, and Remyelination in Multiple Sclerosis.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Rémy Guillevin; Yves Lecarpentier
Journal:  Cell Mol Neurobiol       Date:  2017-09-13       Impact factor: 5.046

8.  Functional cross-talk between beta-catenin and NFkappaB signaling pathways in colonic crypts of mice in response to progastrin.

Authors:  Shahid Umar; Shubhashish Sarkar; Yu Wang; Pomila Singh
Journal:  J Biol Chem       Date:  2009-06-04       Impact factor: 5.157

9.  In vitro study on reversal of ovarian cancer cell resistance to cisplatin by naringin via the nuclear factor-κB signaling pathway.

Authors:  Hong Zhu; Jun Gao; Lei Wang; Ke-Jian Qian; Li-Ping Cai
Journal:  Exp Ther Med       Date:  2018-01-04       Impact factor: 2.447

10.  Long non-coding RNA NKILA regulates expression of HSP90α, NF-κB and β-catenin proteins in the MCF-7 breast cancer cell line.

Authors:  Mehmet Ali Tibatan; Evren Önay Uçar
Journal:  Mol Biol Rep       Date:  2021-06-14       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.